InnoCan Pharma (XCNQ:INNO) Other Current Receivables : C$1.56 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is InnoCan Pharma Other Current Receivables?

InnoCan Pharma's Other Current Receivables for the quarter that ended in Mar. 2025 was C$1.56 Mil.

InnoCan Pharma's quarterly Other Current Receivables declined from Sep. 2024 (C$0.93 Mil) to Dec. 2024 (C$0.76 Mil) but then increased from Dec. 2024 (C$0.76 Mil) to Mar. 2025 (C$1.56 Mil).

InnoCan Pharma's annual Other Current Receivables increased from Dec. 2022 (C$0.31 Mil) to Dec. 2023 (C$0.87 Mil) but then declined from Dec. 2023 (C$0.87 Mil) to Dec. 2024 (C$0.76 Mil).

InnoCan Pharma Other Current Receivables Historical Data

The historical data trend for InnoCan Pharma's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Other Current Receivables Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

1.44

1.23

0.31

0.87

0.76

InnoCan Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Receivables	Get a 7-Day Free Trial															1.23	0.52	0.93	0.76	1.56

InnoCan Pharma Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

InnoCan Pharma Other Current Receivables Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

INNPF:USA IP4:Germany

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

Executives

Peter David Bloch	Director
William Colin Macdonald	Director